天弘恒生沪深港创新药精选50ETF发起联接C(014565)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2024-12-30 |
55,494,018.46 |
52,187,473.51 |
44,492,214.19 |
47,798,759.14 |
| 2024-09-29 |
59,457,369.01 |
55,494,018.46 |
30,955,251.42 |
34,918,601.97 |
| 2024-06-29 |
58,060,995.82 |
59,457,369.01 |
39,038,843.99 |
37,642,470.80 |
| 2024-03-30 |
65,854,285.74 |
58,060,995.82 |
43,905,330.10 |
51,698,620.02 |
| 2023-12-30 |
43,712,400.61 |
65,854,285.74 |
82,424,440.33 |
60,282,555.20 |
| 2023-09-29 |
33,768,214.23 |
43,712,400.61 |
40,267,848.98 |
30,323,662.60 |
| 2023-06-29 |
19,787,696.30 |
33,768,214.23 |
40,260,205.25 |
26,279,687.32 |
| 2023-03-30 |
12,299,347.48 |
19,787,696.30 |
20,555,899.89 |
13,067,551.07 |
| 2022-12-30 |
13,190,816.27 |
12,299,347.48 |
13,045,803.44 |
13,937,272.23 |
| 2022-09-29 |
7,161,562.69 |
13,190,816.27 |
17,246,934.13 |
11,217,680.55 |
微信公众号
证券之星APP
基本资料
